Some inhibitors, such as SBI-477, are reported to be inhibitors of MondoA, and they can retard MondoA from entering the nucleus and may relieve insulin resistance in mice on a high-fat diet (Ahn et al., 2016). Here, MLXIP is linked to Insulin resistance.